[1]叶 玺,叶穗霖,成 莎.止消通脉清热饮治疗冠心病合并糖尿病疗效及对患者心功能和血清孤独G蛋白偶联受体配体-12水平的影响*[J].陕西中医,2020,(11):1584-1586,1590.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.018]
　YE Xi,YE Suilin,CHENG Sha..Effect of Zhixiao Tongmai Qingre decoction on cardiac function and serum Apelin-12 level in patients with coronary heart disease and diabetes mellitus[J].,2020,(11):1584-1586,1590.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.018]
点击复制

止消通脉清热饮治疗冠心病合并糖尿病疗效及对患者心功能和血清孤独G蛋白偶联受体配体-12水平的影响*
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2020年11期
页码:
1584-1586,1590
栏目:
临床研究
出版日期:
2020-11-05

文章信息/Info

Title:
Effect of Zhixiao Tongmai Qingre decoction on cardiac function and serum Apelin-12 level in patients with coronary heart disease and diabetes mellitus
作者:
叶 玺; 叶穗霖; 成 莎
广州医科大学附属中医医院心病科(广州 510130)
Author(s):
YE Xi; YE Suilin; CHENG Sha.
Department of Cardiology,Affiliated Chinese Medicine Hospital of Guangzhou Medical University,Guangzhou Medical University(Guangzhou 510130)
关键词:
止消通脉清热饮;  冠心病;  糖尿病;  心功能;  血糖;  Apelin-12
Keywords:
Zhixiao Tongmai Qingre decoction;  Coronary heart disease;  Diabetes;  Heart function;  Blood glucose;  Apelin-12
分类号:
R541.4
DOI:
DOI:10.3969/j.issn.1000-7369.2020.11.018
文献标志码:
A
摘要:
目的:探讨止消通脉清热饮对冠心病合并糖尿病患者心功能、血糖及血清孤独G蛋白偶联受体配体-12(Apelin-12)水平的影响。方法:选择冠心病合并糖尿病患者80例,随机分为观察组和对照组各40例。对照组给予辛伐他汀、单硝酸异山梨酯及盐酸二甲双胍治疗,观察组在对照组用药基础上给予止消通脉清热饮治疗。比较两组治疗前后心功能指标(LVEF、CO),血糖指标(FBG、2hPG),血清Apelin-12及BNP因子变化。结果:治疗1、2、4周后,两组中医症状积分下降,观察组更明显(P<0.05)。治疗前,两组LVEF、CO、FBG、2hPG、Apelin-12及BNP比较差异无统计学意义(P>0.05); 治疗后,两组LVEF、CO、Apelin-12均升高,FBG、2hPG、BNP均降低(P<0.05); 观察组治疗后LVEF、CO、Apelin-12均高于对照组,FBG、2hPG、BNP均低于对照组(P<0.05)。观察组治疗后生活质量明显优于对照组(P<0.05)。结论:止消通脉清热饮可显著改善冠心病合并糖尿病患者心功能,降低血糖水平,提高血清Apelin-12浓度。
Abstract:
Objective:To investigate the effect of Zhixiao Tongmai Qingre decoction on the cardiac function,blood glucose and serum Apelin-12 level in patients with coronary heart disease and diabetes mellitus.Methods:80 patients with coronary heart disease and diabetes mellitus were randomly divided into control group and observation group with 40 cases in each group.The control group was treated with simvastatin,isosorbide mononitrate and metformin hydrochloride,and the observation group was given Zhixiao Tongmai Qingreyin on the basis of the control group.The changes of heart function index(LVEF,CO),blood glucose index(FBG,2hPG),serum apelin-12 and BNP were compared before and after treatment.Results:After 1,2 and 4 weeks of treatment,the TCM symptom scores of the two groups decreased significantly,and observation group is more obvious(P<0.05).Before treatment,there was no significant difference in LVEF,Co,FBG,2hPG,Apelin-12 and BNP between the two groups(P>0.05); after treatment,LVEF,Co,Apelin-12 increased,FBG,2hPG,BNP decreased,and observation group is more obvious(P<0.05).The quality of life of the observation group after treatment was significantly better than that of the control group(P<0.05).Conclusion:Zhixiao Tongmai Qingre decoction can significantly improve the heart function of patients with coronary heart disease and diabetes mellitus,reduce the level of blood sugar,and increase the concentration of serum apelin-12.

参考文献/References:

[1] 杨晓芬,刘 霞,马鹏飞.氯吡格雷抵抗对冠心病合并糖尿病患者PCI治疗后不良事件的影响[J].陕西医学杂志,2016,45(12):1679-1680.
[2] 高启红,邱守芳,韩岩峰,等.替米沙坦对冠心病合并糖尿病肾病患者临床疗效的影响[J].中华老年心脑血管病杂志,2019,21(7):711-714.
[3] 中华医学会心血管病学分会介入心脏病学组,动脉粥样硬化与冠心病学组,中国医师协会心血管内科医师分会血栓防治专业委员会,等.稳定性冠心病诊断与治疗指南[J].中华心血管病杂志,2018,46(9):680-694.
[4] Durrani S,Rahman UU,Ullah U,et al.Novel risk factors for coronary heart disease in type ii diabetes mellitus [J].Journal of Medical Sciences,2017,25(2):195-199.
[5] 毛积分,黄建新,吕裕霞,等.Apelin 在伴有冠心病高血压患者中的检测意义[J].中国临床保健杂志,2016,19(4):357-359.
[6] 姜文慧,吴秀萍.脂肪因子Apelin与2型糖尿病相关性的研究进展[J].国际生物医学工程杂志,2018,41(2):192-196.
[7] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2013年版)[J].中国糖尿病杂志,2014,30(8):893-942.
[8] Das RN.Relationship between diabetes mellitus and coronary heart disease[J].Curr Diabetes Rev,2016,12(3):285-296.
[9] 解洪涛,张 顺,曾广伟.当归补血方联合西药治疗冠脉搭桥术后疗效及对患者血瘀证证候评分和凝血功能的影响[J].陕西中医,2019,40(10):1341-1344.
[10] 杨宏飞,鄢高亮.血清脂质过氧化物水平在冠心病合并糖尿病介入治疗后的变化[J].安徽医药,2019,23(11):2159-2162.
[11] 张海燕,鞠海兵,崔 涛.2型糖尿病合并冠心病患者的血清非对称二甲基精氨酸水平及其影响因素[J].中国医师杂志,2019,21(6):933-936.
[12] 孙术宁,黄华鑫,黄超原,等.糖尿病合并冠心病用药规律文献研究[J].中医杂志,2018,59(14):1236-1240.
[13] 熊 翼,马浩哲.六味地黄丸对2型糖尿病合并冠心病血糖控制及心血管事件的影响分析[J].内蒙古中医药,2018,37(6):7-8.
[14] 陈 颖,赵立基.益气养阴活血汤联合西药对糖尿病合并冠心病患者临床症状及血清指标的改善作用[J].新中医,2017,49(10):28-31.
[15] 刘 凤,易 华,彭定琼,等.2型糖尿病患者血浆Apelin-12水平与血糖的关系[J].中国动脉硬化杂志,2019,27(3):68-71.

相似文献/References:

[1]孙晓红,刘东敏△.益气强心汤对射血分数中间范围型冠心病心力衰竭患者心脏重塑和生活质量的影响*[J].陕西中医,2020,(10):1392.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.014]
　SUN Xiaohong,LIU Dongmin..Effect of Yiqi Qiangxin decoction on cardiac remodeling and quality of life in patients with heart failure with mid-range ejection fraction[J].,2020,(11):1392.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.014]
[2]吴欣芳,吴 宝,王吉元,等.升陷汤加味治疗冠心病室性早搏临床研究*[J].陕西中医,2020,(11):1563.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.012]
　WU Xinfang,WU Bao,WANG Jiyuan,et al.Effect of Shengxian decoction on ventricular premature beat of coronary heart disease[J].,2020,(11):1563.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.012]
[3]刘紫薇,成泽东,董宝强,等.基于“阴病治阳”理论探讨针刺治疗冠心病[J].陕西中医,2022,(12):1768.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.028]
[4]张 宸,李 景,尚菊菊.2型糖尿病合并冠状动脉硬化患者心率变异性与中医证型相关性分析[J].陕西中医,2023,(1):68.[doi:DOI:10.3969/j.issn.1000-7369.2023.01.016]
　ZHANG Chen,LI Jing,SHANG Juju.Analysis of the correlation between heart rate variability and TCM syndromes in patients with type 2 diabetes mellitus complicated with coronary atherosclerosis[J].,2023,(11):68.[doi:DOI:10.3969/j.issn.1000-7369.2023.01.016]
[5]王 虎,张依轮,姜德友.名中医姜德友基于寒地致病因机特色论治冠心病经验[J].陕西中医,2024,(1):111.[doi:DOI:10.3969/j.issn.1000-7369.2024.01.026]
　WANG Hu,ZHANG Yilun,JIANG Deyou.JIANG Deyou's experience in treating coronary heart disease based on the characteristics of cold regions[J].,2024,(11):111.[doi:DOI:10.3969/j.issn.1000-7369.2024.01.026]
[6]彭华容,王 茜,廖 波,等.三七参芪汤对冠心病患者肥胖且低密度脂蛋白胆固醇未达标的干预价值研究[J].陕西中医,2024,(10):1369.[doi:DOI:10.3969/j.issn.1000-7369.2024.10.016]
　PENG Huarong,WANG Qian,LIAO Bo,et al.Clinical observation of Sanqi Shenqi decoction in the intervention of substandard low-density lipoprotein cholesterol in obese patients with coronary heart disease[J].,2024,(11):1369.[doi:DOI:10.3969/j.issn.1000-7369.2024.10.016]

备注/Memo

备注/Memo:
*广东省中医药局科研项目(2018201)
更新日期/Last Update: 2020-11-09